ORLY
60
-5
JWN
48
-2
OI
42
-3
JNJ
41
3
CAT
59
-2
MAS
52
-4
HBI
58
3
PVH
60
-4
DIS
85
3
CINF
53
3
ED
45
3
TXN
43
-5
BK
74
3
DLTR
38
-4
AIZ
82
2
WDC
37
-3
C
62
4
MO
60
-2
BA
47
2
CNX
73
-3
ORLY
60
-5
JWN
48
-2
OI
42
-3
JNJ
41
3
CAT
59
-2
MAS
52
-4
HBI
58
3
PVH
60
-4
DIS
85
3
CINF
53
3
ED
45
3
TXN
43
-5
BK
74
3
DLTR
38
-4
AIZ
82
2
WDC
37
-3
C
62
4
MO
60
-2
BA
47
2
CNX
73
-3
Financhill
Back

iShares Total Return Active ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
6

BRTR
iShares Total Return Active ETF

Last Price:
50.24
Seasonality Move:
--
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
6
iShares Total Return Active ETF (BRTR) is a Sell

Is iShares Total Return Active ETF a Buy, Sell or Hold?

  • The current iShares Total Return Active ETF [BRTR] share price is $50.16. The Score for BRTR is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • BRTR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRTR Stock Price Chart

What is iShares Total Return Active ETF's stock price today?

  • The iShares Total Return Active ETF share price today is $50.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRTR is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BRTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 33 Sell
Chaikin Money Flow: 12254 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.27 - 51.03) Sell
Bollinger Bands (100): (50.51 - 51.99) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BRTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.31 Sell
20-day SMA: 50.5 Sell
50-day SMA: 51.34 Sell
200-day SMA: 50.67 Sell
8-day EMA: 50.3 Sell
20-day EMA: 50.55 Sell
50-day EMA: 50.97 Sell
200-day EMA: 50.74 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares Total Return Active ETF Earnings Growth & BRTR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

iShares Total Return Active ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):